David A. Siegel Twist Bioscience Corp Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 340,000 shares of TWST stock, worth $14.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
340,000
Previous 87,300
289.46%
Holding current value
$14.8 Million
Previous $3 Million
459.43%
% of portfolio
0.04%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding TWST
# of Institutions
280Shares Held
66.9MCall Options Held
209KPut Options Held
111K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.13MShares$266 Million2.75% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.07MShares$263 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.59MShares$243 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$235 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.42MShares$149 Million0.04% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.45B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...